Dubbed Wixela Inhub, Mylan’s treatment is the first generic of Advair. The FDA approved three dosages of the generic inhaler for twice-daily asthma therapy in patients aged four years and older. It can also be used for the maintenance treatment of airflow obstruction and decreasing exacerbatio...
As for generics, Viatris’ portfolio generated $5.63 billion sales in 2021, up 6%, mainly thanks to its performance in Europe. This figure doesn’t include some complex generics, such as asthma therapy Wixela Inhub, a drug-device generic to GSK’s Advair Diskus. In the U.S. and China,...
Wixela Inhub is the first therapeutically equivalent, substitutable generic version of Advair Diskus (fluticasone propionate/salmeterol) approved for the treatment of asthma and chronic obstructive pulmon... HA Blair - 《Drugs & Therapy Perspectives》 被引量: 0发表: 2019年 ...